Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
0.8 Fte (5)
Lobbyists with EP accreditation
0
High-level Commission meetings
3
Lobbying Costs over the years
-
Info
The Global Alliance for TB Drug Development (TB Alliance)
EU Transparency Register
636752920377-18 First registered on 20 Jan 2016
Goals / Remit
TB Alliance is a not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them.
Main EU files targeted
EU legislative proposal: European Health Emergency Preparedness and Response Authority (HERA) – meetings with European Commission officials; Horizon Europe, European and Developing Countries Clinical Trials Partnership (EDCTP), and EU initiatives connected to research and innovation (R&I) – meetings with European Commission officials; EU Global Health Strategy – meetings with European Commission officials; EU Pharmaceutical Package – contribution to consultation and meetings with European Commission officials
Address
Head Office
80 Pine Street 20th floor
New York 10005
UNITED STATESEU Office
80 Pine Street 20th floor
New York 10005
UNITED STATESWebsite
-
People
Total lobbyists declared
5
Employment time Lobbyists 25% 2 10% 3 Lobbyists (Full time equivalent)
0.8
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 24 Apr 2024
Name Start date End Date Mr Willo BROCK 30 Aug 2019 29 Aug 2020 Ms Erin MORTON 24 Feb 2018 23 Feb 2019 Mr Willo BROCK 20 Jan 2018 19 Jan 2019 Complementary Information
Number of persons includes 2 staff/employees and 3 consultants.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
DSW - https://www.dsw.org/en/eu/
AMR Stakeholder Network - https://epha.org/amr-stakeholder-network/Member organisations
None declared
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
55,774,420€
Major funding types in closed year
Grants
Major contributions in closed year
Type Name Amount Contribution Bill and Melinda Gates Foundation 18,213,779€ Contribution US NIH 5,994,348€ Contribution UK FCDO 12,754,657€ Contribution German BMBF 6,201,129€ Other financial info
TB Alliance is part of a consortium - UNITE4TB being funded under IMI/IHI AMR Accelerator mechanism.
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
We participated in regular meetings with HERA, EDCTP3 and European Commission officials regarding TB Alliance Research and Innovation activities, and actively engaged in communications related to ongoing Commission policies related to EDCTP3 initiatives, EU Global Health Strategy, the EU Pharmaceutical Package and the possibility for the introduction of a novel Priority Review Voucher (PRV) type mechanism to encourage R&I investments in neglected disease research. Furthermore, we highlighted the contributions of the Commission and its various initiatives to support the work of global medical R&I in the context of the "Keeping the Promise: Product Development Partnerships' Role in the New Age of Health Research and Product Development" Report that we help draft and distribute.
Other activities
None declared
- Meetings
Meetings
3 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 14 Oct 2022 Location Brussels Subject Global Gateway Strategy and Global Health Strategy Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 10 Oct 2018 Location Brussels Subject Global Health in Horizon Europe Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Giulia Del Brenna (Cabinet member)
-
Date 25 Jan 2018 Location Brussels Subject EU action to help reduce TB Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Paula Duarte Gaspar (Cabinet member)
Other Lobbyists
- Meetings